Cargando…

Induction of pulmonary HLA-G expression by SARS-CoV-2 infection

The non-classical human leukocyte antigen (HLA)-G exerts immune-suppressive properties modulating both NK and T cell responses. While it is physiologically expressed at the maternal–fetal interface and in immune-privileged organs, HLA-G expression is found in tumors and in virus-infected cells. So f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seliger, Barbara, Jasinski-Bergner, Simon, Massa, Chiara, Mueller, Anja, Biehl, Katharina, Yang, Bo, Bachmann, Michael, Jonigk, Danny, Eichhorn, Philip, Hartmann, Arndt, Wickenhauser, Claudia, Bauer, Marcus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637071/ https://www.ncbi.nlm.nih.gov/pubmed/36334153 http://dx.doi.org/10.1007/s00018-022-04592-9

Ejemplares similares

HLA-G-specific microRNAs a novel approach for targeting tumors
por: Jasinski-Bergner, Simon, et al.
Publicado: (2013)

Role of HLA-G in Viral Infections
por: Jasinski-Bergner, Simon, et al.
Publicado: (2022)

Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies
por: Bauer, Marcus, et al.
Publicado: (2021)

Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma
por: Jasinski-Bergner, Simon, et al.
Publicado: (2016)

Relevance of 2′-O-Methylation and Pseudouridylation for the Malignant Melanoma
por: Jasinski-Bergner, Simon, et al.
Publicado: (2021)

Novel approach to identify putative Epstein–Barr–virus microRNAs regulating host cell genes with relevance in tumor biology and immunology
por: Jasinski-Bergner, Simon, et al.
Publicado: (2022)

Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy
por: Vaxevanis, Christoforos K., et al.
Publicado: (2022)

HLA-E expression and its clinical relevance in human renal cell carcinoma
por: Seliger, Barbara, et al.
Publicado: (2016)

Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant Melanoma
por: Meyer, Stefanie, et al.
Publicado: (2021)

Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells
por: Subbarayan, Karthikeyan, et al.
Publicado: (2022)

The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological Tumors
por: Jasinski-Bergner, Simon, et al.
Publicado: (2022)

Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanoma
por: Fänder, Johannes, et al.
Publicado: (2019)

Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients
por: Lazaridou, Maria-Filothei, et al.
Publicado: (2020)

Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation
por: Quandt, Dagmar, et al.
Publicado: (2014)

Characterization of the expression and immunological impact of the transcriptional activator CREB in renal cell carcinoma
por: Friedrich, Michael, et al.
Publicado: (2020)

Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744
por: Friedrich, Michael, et al.
Publicado: (2020)

Molecular mechanisms of human herpes viruses inferring with host immune surveillance
por: Jasinski-Bergner, Simon, et al.
Publicado: (2020)

The Role of the RNA-Binding Protein Family MEX-3 in Tumorigenesis
por: Jasinski-Bergner, Simon, et al.
Publicado: (2020)

Role of miRs in immune suppression
por: Seliger, Barbara, et al.
Publicado: (2014)

Expression, Regulation and Function of microRNA as Important Players in the Transition of MDS to Secondary AML and Their Cross Talk to RNA-Binding Proteins
por: Bauer, Marcus, et al.
Publicado: (2020)

Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues
por: Subbarayan, Karthikeyan, et al.
Publicado: (2021)

Immune Escape Mechanisms and Their Clinical Relevance in Head and Neck Squamous Cell Carcinoma
por: Seliger, Barbara, et al.
Publicado: (2020)

Role of signal transduction and microRNAs on the immunogenicity of melanoma cells
por: Meyer, Stefanie, et al.
Publicado: (2015)

TGF-β inducible epithelial-to-mesenchymal transition in renal cell carcinoma
por: Tretbar, Sandy, et al.
Publicado: (2019)

Tumor Microenvironment, HLA Class I and APM Expression in HPV-Negative Oral Squamous Cell Carcinoma
por: Wickenhauser, Claudia, et al.
Publicado: (2021)

Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma
por: Schäfer, Helene, et al.
Publicado: (2023)

HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
por: Wuerfel, Franziska M., et al.
Publicado: (2020)

HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers
por: Li, Peilong, et al.
Publicado: (2021)

The Dark Side of Dendritic Cells: Development and Exploitation of Tolerogenic Activity That Favor Tumor Outgrowth and Immune Escape
por: Seliger, Barbara, et al.
Publicado: (2013)

Enhanced function of vaccine dendritic cells from obese donors upon inhibition of the lipid metabolism
por: Massa, Chiara, et al.
Publicado: (2022)

Immune Therapy Resistance and Immune Escape of Tumors
por: Seliger, Barbara, et al.
Publicado: (2021)

Modulation of Lymphocyte Functions in the Microenvironment by Tumor Oncogenic Pathways
por: Seliger, Barbara, et al.
Publicado: (2022)

Combination of multiple omics techniques for a personalized therapy or treatment selection
por: Massa, Chiara, et al.
Publicado: (2023)

Non-invasive screening for subclinical liver graft injury in adults via donor-specific anti-HLA antibodies
por: Höfer, Anne, et al.
Publicado: (2020)

Haplotypes of the HLA-G 3’ Untranslated Region Respond to Endogenous Factors of HLA-G+ and HLA-G- Cell Lines Differentially
por: Poras, Isabelle, et al.
Publicado: (2017)

Altered Spatial Composition of the Immune Cell Repertoire in Association to CD34(+) Blasts in Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia
por: Bauer, Marcus, et al.
Publicado: (2021)

The Induction of IgM and IgG Antibodies against HLA or MICA after Lung Transplantation
por: Paantjens, Annelieke W. M., et al.
Publicado: (2011)

MiRNA Deregulation Distinguishes Anaplastic Thyroid Carcinoma (ATC) and Supports Upregulation of Oncogene Expression
por: Misiak, Danny, et al.
Publicado: (2021)

Current Understanding of the HIF-1-Dependent Metabolism in Oral Squamous Cell Carcinoma
por: Eckert, Alexander W., et al.
Publicado: (2020)

In vitro models as tools for screening treatment options of head and neck cancer
por: Seliger, Barbara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g1mojmklc1b6gs5b048l5v2fpg